Skip to main content

Celldex Therapeutics, Inc 10-Q for FY2024 Q1

Celldex Therapeutics, Inc. (CLDX)

10-Q 2024-05-06 For: 2024-03-31
View Original
Added on April 04, 2026

About this 10-Q

Celldex Therapeutics, Inc filed this 10-Q on May 6, 2024, covering the quarter ended March 31, 2024 (FY2024 Q1).

Headline figures

Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$156K
down 83.9% from $967K a year earlier
Diluted EPS
-$0.56
compared with -$0.62 a year earlier